Vericel Corporation VCEL
$38.95
▼ -2.88% 24H
About
Vericel Corporation is a biopharmaceutical company focused on the development and commercialization of innovative cellular therapies for patients with severe diseases and conditions. The company's primary purpose is to provide next-generation solutions that harness the power of a patient's own cells to repair damaged t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees398
TickerVCEL
Statistics
Market Cap$1.99B
Revenue (TTM)$276.3M
Net Income$16.5M
Net Margin6.0%
EPS$0.32
P/E89.70
P/S6.74
P/B5.52
EV/EBITDA68.80
ROE6.6%
Dividend Yield—
Price$38.95
Data: Twelve Data · Revenue = mcap / P/S